Ananda Pharma PLC - Change of Registered Office
Announcement provided by
Ananda Pharma Plc · ANA03/02/2025 16:35

3 February 2025
ANANDA PHARMA PLC
("Ananda" or the "Company")
Change of Registered Office
Ananda (AQSE: ANA), a Company focused on the development of cannabinoid therapies for the treatment of a range of complex conditions, announces that it has moved its registered office to c/o Arch Law Limited, Huckletree Bishopsgate, 8 Bishopsgate,
-Ends-
The Directors of the Company accept responsibility for the contents of this announcement.
For further information, please contact:
ANANDA DEVELOPMENTS PLC |
+44 (0)7463 686 497 |
|
ir@anandadevelopments.com |
Chief Executive Officer |
|
Melissa Sturgess |
|
|
|
Finance Director |
|
Jeremy Sturgess-Smith |
|
|
|
SP ANGEL CORPORATE FINANCE LLP |
+44 (0)20 3470 0470 |
|
|
Corporate Finance |
|
Richard Morrison |
|
Caroline Rowe |
|
|
|
Corporate Broking |
|
Abigail Wayne |
|
Rob Rees
|
|
Yellow Jersey PR (media enquiries) Sarah MacLeod Charles Goodwin Zara McKinlay |
+44 (0)20 3004 9512 ananda@yellowjerseypr.com |
https://investors.anandapharma.co.uk/link/MP704y
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.